WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010030835) PHARMACEUTICAL COMPOSITIONS OF AN SRC KINASE INHIBITOR AND AN AROMATASE INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/030835    International Application No.:    PCT/US2009/056594
Publication Date: 18.03.2010 International Filing Date: 11.09.2009
IPC:
A61K 45/06 (2006.01)
Applicants: WYETH LLC [US/US]; Patent Law Department Five Giralda Farms Madison, NJ 07940 (US) (For All Designated States Except US).
ZACHARCHUK, Charles, Michael [US/US]; (US) (For US Only).
BOSCHELLI, Frank, Charles [US/US]; (US) (For US Only).
GOLAS, Jennifer, Michele [US/US]; (US) (For US Only).
ARNDT, Kim, Timothy [US/US]; (US) (For US Only)
Inventors: ZACHARCHUK, Charles, Michael; (US).
BOSCHELLI, Frank, Charles; (US).
GOLAS, Jennifer, Michele; (US).
ARNDT, Kim, Timothy; (US)
Agent: JOHNSON, Stephen E.; Wyeth LLC Patent Law Department Five Giralda Farms Madison, NJ 07940 (US)
Priority Data:
61/096,155 11.09.2008 US
61/166,387 03.04.2009 US
Title (EN) PHARMACEUTICAL COMPOSITIONS OF AN SRC KINASE INHIBITOR AND AN AROMATASE INHIBITOR
(FR) COMPOSITIONS PHARMACEUTIQUES À BASE D'UN INHIBITEUR DE LA SRC KINASE ET D'UN INHIBITEUR DE L'AROMATASE
Abstract: front page image
(EN)This invention is directed to a pharmaceutical composition comprising an Src kinase inhibitor and an aromatase inhibitor, and to the use of a combination of an Src kinase inhibitor and an aromatase inhibitor in treating abnormal cell proliferation and abnormal angiogenesis associated with cancer, including breast cancer.
(FR)La présente invention concerne une composition pharmaceutique comprenant un inhibiteur de la Src kinase et un inhibiteur de l'aromatase. L'invention concerne également l'utilisation d'une combinaison d'un inhibiteur de la Src kinase et d'un inhibiteur de l'aromatase dans le traitement d'une prolifération cellulaire anormale et d'une angiogenèse anormale associée à un cancer, y compris le cancer du sein.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)